Healthcare Services Q4 revenue slightly misses

Reuters
02/11
Healthcare Services Q4 revenue slightly misses

Overview

  • Healthcare services manager's Q4 revenue slightly missed analyst expectations

  • Company announced new $75 mln share repurchase program

  • Company expects mid-single-digit revenue growth in 2026

Outlook

  • Healthcare Services Group expects mid-single-digit revenue growth in 2026

  • Company aims to manage 2026 cost of services at 86%

  • Healthcare Services Group anticipates 2026 effective tax rate of 25%

Result Drivers

  • CAMPUS DIVISION GROWTH - Revenue growth driven by Campus division reaching over $100 mln in revenue

  • COST MANAGEMENT - Successfully managed cost of services and SG&A within targeted ranges, contributing to free cash flow generation

  • SHARE REPURCHASE - Completed $50 mln buyback ahead of schedule and authorized new $75 mln program

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Miss*

$466.68 mln

$467.23 mln (5 Analysts)

Q4 EPS

$0.44

Q4 Net Income

$31.24 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the business support services peer group is "buy."

  • Wall Street's median 12-month price target for Healthcare Services Group Inc is $21.00, about 9.1% above its February 10 closing price of $19.24

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release: ID:nBw77cLlza

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10